Association of CYP1B1 haplotypes and breast cancer risk in Caucasian women

Yifan Huang, Amy Trentham-Dietz, Montserrat García-Closas, Polly A. Newcomb, Linda Titus-Ernstoff, John M. Hampton, Stephen J. Chanock, Jonathan L. Haines, Kathleen M. Egan

Research output: Contribution to journalArticlepeer-review

Abstract

CYP1B1 is a key enzyme involved in estrogen metabolism and may play an important role in the development and progression of breast cancer. In a population-based case-controlst udy, we examined eight CYP1B1 haplotype-tagging single nucleotide polymorphisms in relation to invasive breast cancer risk. Analyses were based on 1,655 cases and 1,470 controls; all women were Caucasian. Among the individual single nucleotide polymorphisms, one (rs9341266) was associated with increased risk of breast cancer (Ptrend = 0.021), although the association was no longer significant after adjusting for multiple tests. A marginally significant haplotype effect was identified (P global = 0.015), with significant associations identified for 2 uncommon haplotypes comprising 4% of the controls.Results suggest that genetic variation in CYP1B1 has at most a minor influence on breast cancer susceptibility among Caucasian women.

Original languageEnglish (US)
Pages (from-to)1321-1323
Number of pages3
JournalCancer Epidemiology Biomarkers and Prevention
Volume18
Issue number4
DOIs
StatePublished - Apr 2009

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Fingerprint Dive into the research topics of 'Association of CYP1B1 haplotypes and breast cancer risk in Caucasian women'. Together they form a unique fingerprint.

Cite this